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Medical drugs known to modulate the activity of human ATP-binding cassette (ABC) transporter proteins
(modulators) were tested for the ability to potentiate the activity of the azole fungicide cyproconazole against
in vitro growth ofMycosphaerella graminicola and to control disease development due to this pathogen on wheat
seedlings. In vitro modulation of cyproconazole activity could be demonstrated in paper disk bioassays. Some
of the active modulators (amitriptyline, flavanone, and phenothiazines) increased the accumulation of cypro-
conazole in M. graminicola, suggesting that they reversed cyproconazole efflux. However, synergism between
cyproconazole and modulators againstM. graminicola on wheat seedlings could not be shown. Despite their low
in vitro toxicity to M. graminicola, some modulators (amitriptyline, loperamide, and promazine) did show
significant intrinsic disease control activity in preventive and curative foliar spray tests with wheat seedlings.
The results suggest that these compounds have indirect disease control activity based on modulation of fungal
ABC transporters essential for virulence and constitute a new class of disease control agents.
Plant-pathogenic fungi possess various mechanisms to cope
with the activity of natural toxic compounds that may occur in
their living environments. These compounds can be either an-
tibiotics produced by other microorganisms or plant defense
compounds present in host plants, such as phytoalexins and
phytoanticipins. The mechanisms may involve the evolution of
insensitive target sites, compartmentalization, and metabolism
of toxic compounds into nontoxic products. Another mecha-
nism operating in many organisms involves reduced accumu-
lation of toxic compounds at the target site due to secretion by
ATP-binding cassette (ABC) and major facilitator superfamily
(MFS) transporters (8, 33). These transporters are membrane
pumps that can transport a wide variety of natural products,
including plant antimicrobials. Transport mediated by these
transport systems into the outer environment can significantly
reduce the intracellular concentration of toxicants and protect
organisms with a sensitive target site against toxic activity of
toxic compounds. The validity of this mechanism of natural
insensitivity to natural toxic products was first demonstrated in
studies with a mutant of Staphylococcus aureus that lacks the
multidrug pump NorA (18). The same mechanism has been
described for the ABC transporters BcAtrB and GpAbc1 from
the plant pathogens Botrytis cinerea and Gibberella pulicaris,
which function as virulence factors of these pathogens by pro-
viding protection against the plant defense products resvera-
trol in grapevine and rishitin in potato, respectively (11, 28).
The importance of ABC transporters in virulence has also
been established for ABC transporter mutants of Magnaporthe
grisea and Mycosphaerella graminicola on rice and wheat, re-
spectively. However, the plant defense compounds acting as
substrates for these transporters have not yet been identified
(32, 34). MFS transporters can also mediate natural insensi-
tivity to plant defense compounds, as shown for Bcmfs1 from
B. cinerea and MgMfs1 from M. graminicola (15, 27).
A second physiological function of ABC and MFS transport-
ers from plant pathogens is the secretion of endogenous toxic
products that are relevant for saprophytic survival and viru-
lence on host plants. The known examples are MFS transport-
ers of Cercospora kikuchii, Cochliobolus carbonum, and Fusar-
ium sporothichioides that mediate the secretion of cercosporin,
HT toxin, and trichothecene, respectively (1, 4, 23). These
transporters also function in self-protection against the toxins.
ABC transporters with a similar role in the virulence of plant
pathogens have not been reported, but it is expected that they
do exist.
ABC and MFS transporters belong to the largest protein
families identified. The redundancy of the transporters and
their broad and overlapping substrate specificities explain why
these proteins are also able to transport xenobiotics over bio-
logical membranes. The xenobiotics transported include med-
ical drugs, antibiotics, antimycotics, and agricultural fungicides
(2). In this respect, ABC transporters have become particularly
known for their role in multidrug resistance (MDR), which is
the simultaneous development of resistance against multiple
unrelated chemicals. This phenomenon was first demonstrated
in cancer cells after prolonged treatment with anticancer
drugs. MDR can be based on overexpression of specific ABC
transporters that prevent accumulation of the drugs in cancer
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cells to effective concentrations at their target sites (13). At
present, MDR is also a serious threat to effective control of
bacterial and fungal diseases in mammals and a potential risk
in chemical control of agricultural pests and diseases (9).
The important role of ABC transporters in MDR of cancer
cells has led to wide interest in pharmacological agents that
inhibit the activity of ABC transporters. Such agents are de-
scribed in medical literature as modulators or reversal agents
since they may reduce MDR in oncology (26). The wide inter-
est in these agents has resulted in the discovery of hundreds of
compounds that inhibit ABC transporter activity. Some char-
acteristics of these compounds involve amphiphilic properties,
the presence of aromatic rings, and a positive charge at neu-
tral pH (39). In oncology, modulators are classified as first-
generation modulators (compounds already used in clinics for
other indications), second-generation modulators (analogues
of these drugs), and third-generation modulators (drugs with
original structures developed for the purpose of MDR rever-
sal) (26). Many natural toxic compounds, such as plant alka-
loids and flavonoids, have also been described as multidrug
pump inhibitors (14, 21). Isoflavones have been described as
potentiators of antibacterial activity of natural toxic plant com-
pounds, indicating that they enhance activity of (endogenous)
natural antimicrobial compounds (8, 22). Recently, the syn-
thetic flavonoid derivative 4-hydroxyflavone was identified as
an inhibitor of fungicide efflux in the plant pathogen Pyreno-
phora tritici-repens which is capable of restoring fungicide ac-
tivity against fungicide-resistant isolates to normal wild-type
sensitivity (25). In view of the considerations described above,
modulators of fungal ABC transporters can be regarded as
promising lead compounds for control of disease due to plant
pathogens. The putative ways in which these compounds can
be exploited are summarized in Table 1.
In this study we selected from the literature a number of
modulators representing diverse chemical groups. These com-
pounds were analyzed to determine their in vitro modulation
of azole fungicide activity against isolates of M. graminicola
that differ in sensitivity to azoles. This fungus is considered the
major threat for wheat crops in Europe and causes serious
losses in both bread and durum wheat. Disease management is
based mainly on the use of resistant wheat cultivars and chem-
ical control, particularly with azole fungicides. Compounds
which enhanced the activity of the azole fungicide cyprocon-
azole in vitro were tested further to determine their effects on
accumulation of azole fungicides in mycelium and to deter-
mine their synergistic activities in control of the pathogen.
Some of the modulators selected displayed disease control
activity on their own. The activities of these products were
analyzed further.
MATERIALS AND METHODS
Fungal strains, cultural conditions, and preparation of biomass suspensions.
The M. graminicola strains used in this study were field isolates IPO323 and S190,
originating from The Netherlands and Germany, respectively (19, 31). Strains
IPO323 and S190 are field isolates with relatively high and low sensitivities to
azole fungicides, respectively. Strain IPO323C1 was isolated in the laboratory by
selection for resistance to cyproconazole. This strain has an MDR phenotype
with unrelated compounds, such as cycloheximide and rhodamine 6G (42).
Yeast-like cells and mycelia of these strains were grown in liquid yeast extract-
sucrose medium and Czapek Dox mycological peptone, respectively, as described
previously (42). Cells used for inoculation experiments were harvested by cen-
trifugation at 3,000  g for 10 min at 10°C, washed once in sterile MilliQ water,
and resuspended in 0.15% Tween 20 at a density of 107 cells ml1. Cell suspen-
sions used for accumulation experiments were washed and resuspended in 50
mM potassium phosphate buffer (pH 6.0) containing 10 g liter1 glucose at a
density of 6 mg (wet weight) ml1. Mycelial suspensions used for accumulation
experiments were prepared by filtering cultures with a 0.85-mm-pore-size sieve
and collecting the mycelia on a 0.055-mm-pore-size sieve. The collected mycelia
were washed and resuspended in the same buffer that was used for cell suspen-
sions.
Toxicity bioassays. Paper disks (diameter, 6 mm; Whatman) were saturated in
methanolic solutions of modulators (3,000 mg liter1) and used in paper disk
bioassays. The disks were dried, placed on plates (diameter, 9 cm) with potato
dextrose agar (PDA; 20 ml) seeded with M. graminicola cells (107 cells ml1), and
amended with cyproconazole at sublethal concentrations. Six paper disks per
modulator were used in each plate. The diameters of inhibition zones around the
disks were measured after incubation at 20°C for 14 days. The experiment was
carried out in duplicate and repeated twice. In agar growth bioassays plates
(diameter, 9 cm) with PDA (20 ml) amended with modulators or fungicides at
various concentrations were inoculated in triplicate with 5-l drops of an M.
graminicola cell suspension (4  105 cells ml1) and incubated at 20°C for 10
days. Then MICs that fully inhibited growth were determined.
Crossed-paper-strip bioassay. Filter paper strips (0.7 by 8 cm) were saturated
in methanolic solutions of modulators (3,000 mg liter1) and cyproconazole (1
and 10 mg liter1). The strips were dried and transferred to plates (diameter, 9
cm) containing PDA (15 ml) and seeded with M. graminicola cells (107 cells
ml1). Plates seeded with strain IPO323 contained a strip treated with 1 mg
liter1 cyproconazole, and plates seeded with strains S190 and IPO323C1 con-
tained a strip treated with 10 mg liter1 cyproconazole. The growth patterns
along the paper strips were visually assessed after incubation at 20°C for 14 days.
Foliar spray experiments. The disease control activities of modulators alone
and in combination with cyproconazole were tested in preventive foliar spray
experiments with wheat seedlings (20 seedlings) grown in pots (6 by 6 cm).
Cultivars Obelisk and Vivant were used in experiments with strains IPO323 and
S190, respectively. Foliar spraying was carried out in a spray cabinet equipped
with a turntable. Wheat seedlings (8 days old) were sprayed with modulators
alone (0, 30, 100, 300, and 1,000 mg liter1) and with modulators mixed with
cyproconazole (0.1 mg liter1) for 2 min at a pressure of 0.8  105 Pa, until
runoff. Control seedlings were sprayed with 0.15% Tween 20. The seedlings were
dried overnight and subsequently sprayed with cell suspensions of M. graminicola
TABLE 1. Putative functions of ABC transporters from plant pathogens and exploitation of modulators of these proteins in disease control
Function of ABC transporters Effect of modulators
Prevention of accumulation of plant defense
products in fungal cells during pathogenesis .........................................................Increased accumulation of plant defense products in fungal
cells resulting in reduced fungal growth and colonization of
plant tissue
Secretion of fungal toxins with a role in virulence ...................................................Suicidal activity on the producing fungus; reduced virulence on
host plants
Reduction of sensitivity of plant pathogens to
fungicides with a sensitive target site......................................................................Synergistic activity between modulators and fungicides resulting
in a wider spectrum of antifungal activity of fungicide
MDR of plant pathogens..............................................................................................Reversal of MDR to wild-type sensitivity of multiple chemicals
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strains at a density of 107 cells ml1 in 0.1% Tween 20. Inoculated plants were
placed on water-soaked cloths in sealed containers with Perspex lids at 18°C in
climate rooms in the dark. Control plants and plants treated with modulators
were placed in separate boxes in order to avoid the effects of possible vapor-
phase activity. After 2 days of incubation a 16-h daylight period was applied.
Emerging second leaves were clipped every 4 to 5 days to facilitate disease
assessment and light penetration. Virulence was assessed visually by evaluation
of necrotic leaf areas (10 leaves per treatment) and the abundance of pycnidia in
necrotic lesions at 16 and 21 days postinoculation (dpi). An estimate of the
expected interaction between cyproconazole (0.1 mg liter1) and modulators (30
and 300 mg liter1) was calculated using the equation of Colby (5): E  XpYq/
100, where E is the expected disease expressed as a percentage of the control for
the mixture of compounds A and B (at concentrations p and q) and Xp and Yq are
the observed disease levels expressed as a percentage of the control with a single
compound (compound A at concentration p or compound B at concentration q).
A deviation from the expected response indicates synergism or antagonism.
Curative foliar spray experiments were performed by application of compounds
in a way similar to the way described above but 1 day after fungal inoculation.
The experiments were carried out in triplicate.
Accumulation of cyproconazole. Cell and mycelial suspensions (55 ml) were
incubated in flasks (300 ml) at 25°C and 140 rpm for 30 min. At zero time
[14C]cyproconazole (Syngenta, Basel, Switzerland) was added to an external
concentration of 100 M (1.5 MBq mmol1). Modulators were added 30 min
after the addition of cyproconazole to external concentrations of 100 and 300
M. Amitriptyline, chlorpromazine, flavanone, and promazine at a concentra-
tion of 300 M are equivalent to 94, 96, 47, and 106 mg liter1, respectively. Cells
and mycelia were harvested at intervals by vacuum filtration of samples (5 ml)
and washed five times with 5 ml of phosphate buffer (pH 6.0), and the radioac-
tivity in the biomass was measured with a Beckman LS6000TA liquid scintillation
counter. Accumulation of [14C]cyproconazole was expressed as nmol mg (dry
weight) of biomass1 (42).
RESULTS
Selection of experimental modulators. In a classical over-
view of drugs that alter MDR in cancer cells, Ford and Hait
(12) categorized modulators as calcium channel blockers, cal-
modulin antagonists, Vinca alkaloids, steroids, hormonal ana-
logs, and miscellaneous hydrophobic cationic compounds (Ta-
ble 2). Since that study numerous other modulators have been
described, and a number of them are also listed in Table 2.
Modulators used in the present study are indicated. Calcium
channel blockers and cyclosporins were not included since
similar experiments with B. cinerea were not successful (16). A
relatively large number of phenothiazines were selected be-
cause some of these compounds showed strong synergistic ac-
tivity with the azole fungicide oxpoconazole against B. cinerea
in vitro (16). Most of the polyphenol and flavonoid modulators
listed in Table 2 are natural products that occur abundantly in
plants, including food crop species. This suggests that the
mammalian toxicity of these compounds is low. Modulation of
fungal ABC transporters by plant polyphenols and flavonoids
may imply that these compounds can enhance the activity of
the plants’ own natural antimicrobial compounds. Such a
mechanism might contribute to the basal insensitivity of a
nonhost plant to plant pathogens. In order to test this hypoth-
esis, relatively large numbers of polyphenol and flavonoid
compounds were tested. The flavonoid 2-(4-ethoxy-phenyl)-
chromen-4-one was described as an azole efflux inhibitor of P.
tritici-repentis (25). Since this compound is not commercially
available, we tested the structural analogue 5,7-dimethoxy-2-
phenyl-chromen-4-one.
Interaction between cyproconazole and modulators in paper
disk bioassays. The experimental modulators with fungitoxic
activity against most of the M. graminicola strains tested were
amitriptyline, the phenothiazines chlorpromazine, promazine,
and thioridazine, diethylstilbestrol, and flavanone (Table 3).
Phenothiazines had relatively high fungitoxic activity. The ac-
tivity of amitriptyline seemed to be weaker against strain S190
than against wild-type strain IPO323. For most of these com-
pounds the inhibition zones in plates with cyproconazole were
larger than those in plates without the fungicide, suggesting
that the compounds did potentiate cyproconazole activity. The
phenothiazines had a relatively strong effect against all M.
graminicola strains tested, suggesting that these compounds
are interesting candidates for further research. The experimen-
tal modulators without fungitoxic activity under the test con-
ditions used included plant alkaloids, polyphenols, and fla-
vonoids (Table 3). Most of these compounds did not potentiate
the activity of cyproconazole; the only exceptions were imipra-
mine and loperamide in tests with strain IPO323.
TABLE 2. Compounds described in literature as modulators of drug efflux from cancer cells
Category Examples of compoundsa Pharmacological properties Reference(s)
Calcium channel blockers Verapamil, nifedipine, and related
compounds from different structural
classes
Coronary vasodilator 12
Calmodulin antagonists Phenothiazines like chlorpromazine,
promazine, and thioridazine
Antipsychotic drug 12, 20
Alkaloids Camptothecin, vinblastine, vincristine, and
related products
Cytotoxic activity 12, 24
Steroids and hormonal analogs Progesteron, diethylstilbestrol Hormonal activity 12, 29
Miscellaneous hydrophobic
cationic compounds
Quinidine, reserpine Antiarrhythmic activity 12
Natural polyphenols and
synthetic derivatives
Chrysin, epicathechin, genistein, naringenin,
quercetine, resorcinol, rutin
Secondary plant metabolites; important
constituents of human daily food
6, 17, 35, 38
Flavonoids Flavanone, flavone, flavonol, isoflavones,
flavolignan
Secondary plant metabolites; important
constituents of human daily food
21
Cyclosporine derivatives Cyclosporine A Immunosuppressive activity 29
Rifamycin derivatives Rifamycin B Antibacterial drug 7, 10
Opioids Loperamide Antidiarrheal drug 37
Tricyclic serotonin reuptake
inhibitors
Amitriptyline, imapramin Antipsychotic drug 36
a Compounds in bold were used in the present study.
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Interaction between cyproconazole and modulators in
crossed-paper-strip bioassays. All compounds were screened
for modulating activity with cyproconazole in crossed-paper-
strip bioassays with M. graminicola IPO323, S190, and
IPO323C1. The phenothiazines chlorpromazine, promazine,
and thioridazine clearly synergized the activity of cyprocon-
azole. The modulating activities of these compounds with
strain IPO323 are shown in Fig. 1. Diethylstilbestrol, fla-
vanone, loperamide, naringenin, and quinidine showed weak
synergistic interactions with cyproconazole only for growth of
strain IPO323C1. Most other interactions tested were indepen-
dent; the only exception was the interaction with resorcinol,
which antagonized the activity of cyproconazole with all strains
tested, especially strain S190.
MICs of modulators in agar growth tests. The MICs of eight
experimental modulators with synergistic activity in mixtures
with cyproconazole in paper disk bioassays were determined in
agar growth tests. Rutin, which did not display any synergism,
and cyproconazole itself were included as controls. Table 4
shows that the toxicities of the modulators towards M. gramini-
cola IPO323 and S190 are low compared to that of cyprocon-
azole. For strain IPO323, the ratio of the MIC of the modu-
lator to the MIC of cyproconazole was 1.000 or even higher for
most of the modulators tested. A relatively low value was
found only for diethylstilbestrol (ratio, 100). The MICs of two
of the three phenothiazines tested (promazine and thiorid-
azine) correlated with the MICs of cyproconazole for strain
IPO323 and S190.
TABLE 3. Activities of putative modulators of ABC transporter activity in paper disk bioassays in the absence and presence of
cyproconazole for growth of M. graminicola strains IPO323 (wild type), IPO323C1 (cyproconazole-resistant laboratory
mutant), and S190 (field isolate with relatively low cyproconazole sensitivity)
Modulator
Diam of growth inhibition zone (mm)a













Control 0 0 0 0 0 0
Amitriptyline 2.2 0.7 2.2  0.7 1.0 0.6 2.0  0.6b 0 1.4  1.4b
Camptothecin 0 0 0 0 0 0
Chlorpromazine 4.3 1.1 5.3  0.4b 5.0  1.2 8.5  2.7b 3.8  0.4 5.3  0.4b
Chrysin 0 0 0 0 0 0
Cyclosporine 0 0 0 0 0 0
Diethylstilbestrol 1.4 0.5 2.2  0.4b 0 2.8  0.4b 1.0  0.6 1.6  0.8
Epicathechin 0 0 0 0 0 0
Flavanone 1.0 0 2.0  0b 1.4  0.5 2.0  0.6b 2.2  0.4 3.4  0.5b
Imipramine 0 0.5 0.5 0 0 0 0
Loperamide 0 0.3 0.4 0 0 0 0
Naringenin 0 0 0 0 0 0
Promazine 1.8 1.1 4.0  1.2b 1.8  0.4 2.3  0.4 0.8 0.4 2.0  0b
Quercetin 0 0 0 0 0 0
Quinidine 0 0 0 0 0 0
Reserpine 0 0 0 0 0 0
Resorcinol 0 0 0 0 0 0
Rutin 0 0 0 0 0 0
Thioridazine 4.5 0.5 6.5  0.5b 4.0  0.7 7.3  0.8b 5.8  0.8 6.5  0.5
Verapamil 0 0 0 0 0 0
5,7-Dimethoxy-2-chromen-4-one 0 0 0 0 0 0
a The values (means  standard deviations) are the diameters of the zones of growth inhibition around disks impregnated with modulators (3,000 mg liter1). The
cyproconazole concentration was 0.001 mg liter1 in agar plates seeded with IPO323 and 0.01 mg liter1 in plates seeded with IPO323C1 and S190.
b The values for plates with and without cyproconazole differ significantly (P  0.05).
FIG. 1. Synergistic activity between cyproconazole and the putative modulators of ABC transporter activity chlorpromazine, promazine, and
thioridazine against growth of M. graminicola strain IPO323 in crossed-paper-strip experiments. The horizontal strips were impregnated with
cyproconazole (1 mg liter1 in methanol), and the vertical strips were impregnated with the modulators (3,000 mg liter1 in methanol).
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Disease control activities of modulators. The disease control
activities of some of the experimental modulators listed in
Table 4 were tested using M. graminicola strains IPO323 and
S190 and cultivar Obelisk and Vivant wheat seedlings, respec-
tively, in preventive foliar spray experiments. In control treat-
ments, the first symptoms became visible at 8 dpi as small
chlorotic spots near the tips of the leaves. In time, the lesions
expanded longitudinally across the leaves and developed into
necrotic lesions covered with pycnidia. At 21 dpi, the percent-
ages of the leaf area with these symptoms for cultivars Obelisk
and Vivant were 64% and 87%, respectively. The disease con-
trol activities of eight modulators were studied (Table 5). All
compounds showed significant disease control activity in treat-
ments with 30 and 300 mg liter1 (P 	 0.05). Promazine was
the most active compound against strain IPO323 on wheat
cultivar Obelisk since the disease control activity was 97% of
the control. The disease control activities for the other com-
pounds varied from 23 to 85% (Table 5). The disease control
activities of the modulators against strain S190 on wheat cul-
tivar Vivant were also obvious. Amitriptyline and quinidine
were the most active compounds, showing up to 78% disease
control activity (Table 5). Treatment of plants with modulators
at a concentration of 1,000 mg liter1 or higher caused phyto-
toxic symptoms, visible as necrotic lesions at 10 dpi (results not
shown). Visible necrotic symptoms were not observed at a
concentration of 300 mg liter1 or lower.
Experimental modulators with relatively high disease con-
trol activity in the preventive foliar spray tests (amitriptyline,
loperamide, and promazine) were studied further in curative
foliar spray tests by applying foliar sprays with the compounds
1 day after inoculation of the wheat seedlings. Disease devel-
opment was assessed at 16 and 21 dpi (Fig. 2). Figure 2 shows
that all compounds tested had a significant effect on disease
development, especially at 16 dpi. At 21 dpi, the disease con-
trol activity was still obvious but less than that at 16 dpi,
indicating that the activity of modulators is transient in time.
Disease control activities of mixtures of modulators and
cyproconazole. Interactions between experimental modulators
and cyproconazole in disease control were studied using mix-
tures of modulators at 30 and 300 mg liter1. The cyprocon-
azole concentration in the mixtures was set at 0.1 mg liter1
since preliminary experiments demonstrated that this concen-
tration controlled about 50% of the disease in foliar spray
experiments, which is the optimal percentage to study syner-
gism with other compounds (Table 6). The experiments were
performed simultaneously with the experiments to assess the
disease control activity of modulators using preventive foliar
spray (Table 5). An overview of the observed and expected
necrotic leaf areas in disease control experiments with M. gra-
minicola strains IPO323 and S190 on wheat cultivars Obelisk
TABLE 4. MICs of modulators and cyproconazole for growth of
M. graminicola strains IPO323 and S190 in agar growth tests
Compound
MIC (mg liter1)






















TABLE 5. Activities of compounds described in literature as modulators of ABC transporters in the control of M. graminicola on
wheat seedlings in preventive foliar spray experiments
M. graminicola
strain Wheat cultivar Modulator
Necrotic area of leaves treated with
modulator at the following concn,
expressed as % of controla:
Disease control by modulator at
the following concn, expressed
as % of controlb:
30 mg liter1 300 mg liter1 30 mg liter1 300 mg liter1
IPO323 Obelisk Amitriptyline 34.1 8.9 62.2  5.2 65.9 37.8
Chlorpromazine 59.3 4.4 43.7  5.2 40.7 56.3
Diethylstilbestrol 32.6  10.0 23.7 8.1 67.4 76.3
Flavanone 62.2 11.8 63.7 3.7 37.8 36.3
Loperamide 46.7 5.2 14.1  8.9 53.3 85.9
Promazine 15.6 5.2 3.0  2.2 84.4 97.0
Quinidine 76.3 8.1 77.8  4.4 23.7 22.8
Thioridazine 31.1 8.1 17.0  4.4 68.9 83.0
S190 Vivant Amitriptyline 31.0 9.5 24.3  5.2 69.0 75.7
Chlorpromazine 62.0 11.2 24.0 7.2 38.0 76.0
Diethylstilbestrol 73.0  15.3 47.9 5.4 27.0 52.1
Flavanone 52.5 11.0 36.3 8.1 47.5 63.7
Loperamide 51.1 4.6 58.2  8.0 48.9 41.8
Promazine 44.3 7.5 27.8  3.3 55.7 72.2
Quinidine 38.9 7.4 21.6  5.1 61.1 78.4
Thioridazine 49.3 4.3 68.0  11.6 50.7 32.0
a The necrotic area of leaves represents the leaf area with disease symptoms. The necrotic areas (means  standard deviations) for the control treatment with strains
IPO323 and S190 were 64.0%  6.6% and 87.1%  13.2%, respectively (defined as 100%).
b The disease control by modulators represents the healthy leaf area in treatments.
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and Vivant indicated that the observed necrotic areas on leaves
treated with mixtures were similar to or larger than the ex-
pected necrotic leaf areas, suggesting that that there were no
synergistic activities for the interactions tested (Table 6).
Effect of modulators on accumulation of cyproconazole. Ac-
cumulation of cyproconazole in the absence of experimental
modulators in both yeast-like cells and mycelium of M. gra-
minicola IPO323 and S190 was slightly transient in time (Fig.
3). The levels accumulated by strain S190 were higher than the
levels accumulated by strain IPO323. Addition of all modula-
tors tested caused an instantaneous increase in cyproconazole
accumulation. For most modulators the increase in fungicide
accumulation was transient. The exception was chlorproma-
zine added to yeast-like cells. In this case, the level of cypro-
conazole that accumulated remained at an almost constant
elevated value. Modulators added to mycelial and cell suspen-
sions at a final concentration of 100 M had similar effects on
accumulation of cyproconazole, but the effects were less pro-
nounced (results not shown). Loperamide, quinidine, and thi-
oridazine (300 M) did not significantly enhance accumulation
of cyproconazole in either cells or mycelium (results not
shown).
DISCUSSION
Several modulators described in the literature as compounds
that alter MDR in cancer cells were also able to increase the
activity of the azole fungicide cyproconazole against M. gra-
minicola. This activity could be demonstrated for amitriptyline,
diethylstilbestrol, flavanone, and the phenothiazines chlor-
promazine, promazine, and thioridazine in paper disk bioas-
says with three strains of the pathogen that differ in sensitivity
to cyproconazole. The modulating activity of the phenothia-
zines was also apparent in crossed-paper-strip experiments.
These results corroborate the synergistic activities of chlor-
promazine and cyproconazole against M. graminicola, as re-
ported previously (30). Chlorpromazine can also modulate the
activity of azole fungicides against B. cinerea, particularly an
azole-secreting, ABC transporter BcatrD overexpression mu-
tant (16). Additional studies demonstrated that amitriptyline,
chlorpromazine, flavanone, and promazine had instantaneous
effects on the levels of cyproconazole accumulated in yeast-like
cells and mycelium of M. graminicola, suggesting that cypro-
conazole efflux by fungal drug transporters was inhibited.
Chlorpromazine had a relatively strong effect since its reversal
of efflux activity remained almost constant over time. This
characteristic of chlorpromazine may be related to its relatively
strong modulating activity in the in vitro assays. The modulat-
ing activity may be due to affinity of the modulators to binding
sites of ABC transporter proteins which results in inhibition of
cyproconazole transport (40).
Several ABC transporters of M. graminicola that can provide
protection against azole fungicides have been described (41).
Hence, it might be that reversal of the activity of one or more
of these ABC transporters in M. graminicola by the phenothia-
zines or other compounds tested is responsible for the syner-
gism with cyproconazole. The MFS transporter MgMfs1 has
also been described as a potent transporter of azole fungicides
(27). However, the compounds tested are not described in the
literature as modulators of MFS transporters, and therefore
modulation of MgMfs1 by phenothiazines is probably not re-
sponsible for the synergism observed.
Various models have been described to explain reversal of
drug efflux activity mediated by ABC transporters (3). A pro-
posed mechanism of action is direct binding of the modulator
to a binding site(s) on the transporter protein, which results in
blocking transport in either a competitive or noncompetitive
mode (40).
Foliar spray experiments with mixtures of cyproconazole and
modulators demonstrated that the expected disease control
activity calculated as described by Colby (5) was merely addi-
tive or even antagonistic. Thus, none of the modulators tested
showed synergism with cyproconazole in planta, not even the
modulators exhibiting synergism in vitro. This situation con-
trasts with the modulating activity reported for a 4-hydroxy-
flavone derivative for resistance to azoles and other fungicides
in P. tritici-repens (25), but it is not uncommon for MDR
modulators in clinical situations (26). There are several rea-
sons that could explain the lack of in planta modulating activ-
ity: (i) the in planta-mediated degree of natural insensitivity or
FIG. 2. Activities of amitriptyline, loperamide, and promazine in
control of M. graminicola IPO323 on cultivar Obelisk wheat seedlings
in curative foliar spray tests. The concentrations of the compounds
tested were 1 mg liter1 (open bars), 10 mg liter1 (gray bars), and 100
mg liter1 (black bars). Disease was assessed at 16 and 21 dpi. The bars
indicate the mean percentages of necrotic leaf area with pycnidia, and
the error bars indicate standard deviations.
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resistance of M. graminicola through ABC transporters is too
low to show an interaction; (ii) the mixtures of fungicide and
modulators may have had a phytotoxic or senescent effect on
wheat, promoting its susceptibility to the pathogen; and (iii)
cyproconazole is a systemic fungicide, while the modulators
probably have only a residual effect on the leaf surface. These
different properties may result in a rapid spatial separation of
the two compounds in plant tissues, and once the pathogen has
invaded the host via the stomatal cavities, it is exposed only to
the fungicide. For these reasons similar experiments with an
MDR strain of M. graminicola with high levels of resistance
and a systemic modulator without phytotoxicity are recom-
mended. However, field isolates with such a phenotype are not
available. Laboratory mutants that possess MDR phenotypes
(e.g., strain IPO323C1) are impaired in virulence on wheat,
and systemic modulators are not known.
All experimental modulators tested individually controlled
M. graminicola on wheat seedlings in preventive foliar spray
experiments (Table 5). A curative foliar spray test (16 dpi) with
amitriptyline, loperamide, and promazine demonstrated that
at relatively low concentrations disease control is especially
evident during the initial phase of disease development (Fig.
2). The reduced disease control activity observed later (21 dpi)
can probably be ascribed to physical and metabolic breakdown
of the compounds. The disease control efficacy of the com-
pounds may be explained in different ways. One possibility is
that the presence of the modulators leads to reversal of ABC
transporters that act as pathogenicity factors, such as MgAtr4
(32). Thus, as shown in Table 1, modulator disease control
activity can be ascribed to increased accumulation of plant
defense products in the pathogen or reduced secretion of fun-
gal toxins. This may apply particularly to modulators such as
amitriptyline, loperamide, and promazine, which did not pos-
sess in vitro toxicity to M. graminicola in agar growth tests
(Table 4). Compounds active in such a way can be regarded as
disease control agents with an indirect mode of action. This
hypothesis is difficult to verify since a clear role of fungal toxins
and plant defense compounds in the interaction of M. gramini-
cola and wheat has not been elucidated. Most of the other
modulators that possessed disease control activity have low or
moderate direct toxicity to M. graminicola in vitro (chlorprom-
azine, diethylstilbestrol, flavanone, promazine, and thiorid-
azine). This may imply that the disease control activity of these
compounds may be a consequence of both modulation of ABC
transporter activity and direct activity against M. graminicola.
For instance, the MICs of diethylstilbestrol and cyproconazole
for in vitro growth were 30 and 0.3 mg liter1, respectively,
indicating that the toxicity ratio of the two compounds is 100
(Table 5). If the same ratio applied for disease control activity
on wheat seedlings, approximately 50% disease control would
be expected with diethylstilbestrol at a concentration of 10 mg
liter1 (50% disease control by cyproconazole is obtained at
0.1 mg liter1) (Table 6). Indeed, disease control by diethyl-
stilbestrol occurs with concentrations that are this order of
magnitude, and for this reason disease control by this com-
pound is probably due to direct toxicity to the pathogen. For
compounds with an MIC of 300 mg liter1 (chlorpromazine,
flavanone, and promazine) similar reasoning is less obvious
since their toxicity ratio with cyproconazole (1,000) probably
cannot be fully explained by direct toxicity. Amitriptyline and
loperamide belonged to the category of compounds with the
highest MICs determined (
300 mg liter1). Still, these com-
pounds displayed relatively high disease control activity in both
preventive and curative disease control tests at low concentra-
tions. For these reasons it is likely that the disease control
TABLE 6. Interactions between cyproconazole and modulators in control of M. graminicola on wheat seedlingsa
Modulator in mixture with
cyproconazole (0.1 mg liter1)b
Necrotic leaf areas of wheat seedlings sprayed with mixtures of cyproconazole and modulators
Cultivar Obelisk inoculated with
M. graminicola IPO323










Amitriptyline (30 mg liter1) 68.5  5.2 14.7 28.1 9.4 18.3
Amitriptyline (300 mg liter1) 32.6  5.3 26.7 16.6 5.6 14.4
Chlorpromazine (30 mg liter1) 50.2  5.0 25.4 43.4 9.0 36.6
Chlorpromazine (300 mg liter1) 20.6  8.9 18.8 24.9 14.0 14.2
Diethylstilbestrol (30 mg liter1) 34.0  2.2 13.8 36.1 9.6 43.1
Diethylstilbestrol (300 mg liter1) 18.7  6.7 10.2 62.6 9.4 28.2
Flavanone (30 mg liter1) 59.2  10.0 26.7 31.5 7.7 31.0
Flavanone (300 mg liter1) 50.0  11.8 27.4 22.8 4.2 21.4
Loperamide (30 mg liter1) 17.0  3.7 20.1 51.5 6.3 30.1
Loperamide (300 mg liter1) 20.1  5.2 6.1 38.3 4.1 34.3
Promazine (30 mg liter1) 3.0  3.0 6.7 25.1 5.2 26.1
Promazine (300 mg liter1) 11.0  5.2 1.3 20.7 3.4 16.4
Quinidine (30 mg liter1) 70.0  8.8 32.8 34.1 4.7 23.0
Quinidine (300 mg liter1) 62.0  8.0 33.4 13.4 5.6 12.7
Thioridazine (30 mg liter1) 27.7  7.0 13.3 45.9 2.7 29.1
Thioridazine (300 mg liter1) 11.0  8.7 7.3 43.3 6.4 40.1
a The results were obtained in experiments performed simultaneously with the disease control experiments with individual compounds described in Table 5.
b The necrotic areas of leaves sprayed with cyproconazole (0.1 mg liter1) expressed as percentages (averages standard deviations) of the control in the experiments
with strains IPO323 and S190 were 43.0%  4.8% and 59.0%  8.0, respectively.
c The values are the necrotic areas of leaves (averages  standard deviations) expressed as percentages of the water controls.
d The expected necrotic leaf area was calculated as described by Colby (5), using values for necrotic leaf areas obtained for single treatments with cyproconazole and
modulators.
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activity of amitriptyline, loperamide, and promazine is due to
an indirect mode of action and not due to direct toxicity.
Remarkably, modulators with the highest disease control
activity against M. graminicola (amitriptyline, loperamide, and
promazine) also potentiate the activity of cyproconazole in
paper disk bioassays. As described above, these two character-
istics of modulators are not necessarily due to reversal of
activity of the same ABC transporter(s). This reasoning implies
that the modulators inhibit the activity of multiple ABC trans-
porters and indicates that the compounds have no reversal
selectivity. Such a property would make the in vitro selection of
new reversal agents in bioassays as described in this paper
easier. The modulators tested did not display phytotoxicity at a
concentration of 100 mg liter1 in foliar spray tests. This indi-
cates that selective toxicity for different groups of organisms is
feasible.
In conclusion, the results reported in this paper describe the
first steps in the discovery and development of modulators of
ABC transporter activity which potentiate the activity of azole
fungicides towards plant pathogens and which may possess
indirect disease control activity. The modulators with disease
control activity are amitriptyline, loperamide, and promazine,
which are known chemical drugs used for control of human
diseases. The second step in the development of disease con-
trol agents could be the synthesis and screening of structural
analogues of these compounds for improved biological activity,
systemic activity in plants, and selective activity against plant
pathogens and other classes of organisms. As a third step
modulators with a new chemical structure can be developed. A
similar sequence of events has been described for the devel-
opment of modulators for clinical use (26).
ACKNOWLEDGMENTS
We acknowledge P. J. G. M. de Wit for critically reading the manu-
script and J. G. M. van Nistelrooij for skillful assistance with the
accumulation experiments.
We acknowledge the Agricultural Research and Education Organi-
zation (AREO) of Iran and the Iranian Ministry of Science, Research,
and Technology for financial support of Ramin Roohparvar.
FIG. 3. Effects of modulators on accumulation of [14C]cyproconazole (100 M) by mycelium and yeast-like cells of M. graminicola IPO323 and
S190. The modulators (300 M) amitriptyline (), chlorpromazine (E), flavanone (‚), and promazine () were added 30 min after the addition
of cyproconazole (dashed line). , control treatment. The error bars indicate the standard deviations of the means.
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